Brought to you by:

Cell & Gene Therapy

Explore news and insight around cell and gene therapy, including new technology and information in this evolving biotech field. Read on to understand how the industry is addressing gene therapy and cell therapy research and development.

Brought to you by:
reducing people on team
Biotech

ArsenalBio halves staff amid reorganization efforts

The shift to a clinical focus does not impact the Bay Area biotech’s long-standing collaboration with BMS, an ArsenalBio spokesperson said.
Darren Incorvaia Sep 17, 2025 4:55pm
Job cuts employee layoffs firings or downsizing Scissors dividing individuals positioned on colorful blocks

Innate loses 30% of workforce in focus on 'highest-value assets'

Sep 17, 2025 5:16am
Network of blood vessels against a white background

Custom gene editor fixes mutation causing deadly disease in mice

Sep 11, 2025 1:48pm
pause button on blue background

Capsida pauses phase 1 gene therapy trial after child dies

Sep 11, 2025 7:30am
Manila folder with CONFIDENTIAL printed on it in red

Capricor responds to cell therapy snub, disputes FDA’s concerns

Sep 9, 2025 11:44am
Sign warning about erosion on a cliff

Gilead's Kite erodes $2.3B Shoreline cell therapy deal

Sep 3, 2025 3:18pm
More News

Editas plans to target high cholesterol with gene editing

Sep 2, 2025 1:46pm

Paul Allen research foundation unveils with $500M funding plan

Aug 27, 2025 11:59am

Wugen woos VCs, landing $115M to bring CAR-T therapy to market

Aug 27, 2025 8:10am

Lineage tunes up hearing loss transplant with $12M research pact

Aug 26, 2025 11:00am